Tetra Discovery Partners Lands $1,041,000 Seed Financing Round

  • Feed Type
  • Date
    10/2/2013
  • Company Name
    Tetra Discovery Partners
  • Mailing Address
    301 Michigan Street NE Grand Rapids, MI 49503
  • Company Description
    Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
  • Website
    http://www.tetradiscovery.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,041,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The company intends to use the funds to develop an innovative drug to treat cognitive impairment caused by Alzheimer’s disease, and a second drug to treat depression and restore cognitive function in patients who have suffered traumatic brain injury (TBI).
  • M&A Terms
  • Venture Investor
    Grand Angels
  • Venture Investor
    Biosciences Research and Commercialization Center
  • Venture Investor
    Michigan Pre-Seed Capital Fund
  • Venture Investor
    Michigan Economic Development Corporation

By posting a comment, you agree to our terms and conditions.